全文获取类型
收费全文 | 526604篇 |
免费 | 34618篇 |
国内免费 | 678篇 |
专业分类
耳鼻咽喉 | 7087篇 |
儿科学 | 17087篇 |
妇产科学 | 13691篇 |
基础医学 | 86482篇 |
口腔科学 | 14958篇 |
临床医学 | 45042篇 |
内科学 | 96487篇 |
皮肤病学 | 12354篇 |
神经病学 | 37216篇 |
特种医学 | 19118篇 |
外国民族医学 | 63篇 |
外科学 | 79683篇 |
综合类 | 8496篇 |
一般理论 | 118篇 |
预防医学 | 39271篇 |
眼科学 | 12304篇 |
药学 | 41513篇 |
中国医学 | 995篇 |
肿瘤学 | 29935篇 |
出版年
2018年 | 5192篇 |
2016年 | 4302篇 |
2015年 | 4742篇 |
2014年 | 6404篇 |
2013年 | 9950篇 |
2012年 | 13547篇 |
2011年 | 14944篇 |
2010年 | 8743篇 |
2009年 | 8169篇 |
2008年 | 14362篇 |
2007年 | 15359篇 |
2006年 | 15648篇 |
2005年 | 15089篇 |
2004年 | 14747篇 |
2003年 | 14058篇 |
2002年 | 13956篇 |
2001年 | 24709篇 |
2000年 | 25729篇 |
1999年 | 21075篇 |
1998年 | 5358篇 |
1997年 | 4585篇 |
1996年 | 4915篇 |
1995年 | 4718篇 |
1994年 | 4412篇 |
1992年 | 16135篇 |
1991年 | 16669篇 |
1990年 | 16763篇 |
1989年 | 16207篇 |
1988年 | 14916篇 |
1987年 | 14716篇 |
1986年 | 13896篇 |
1985年 | 13273篇 |
1984年 | 9834篇 |
1983年 | 8378篇 |
1982年 | 4611篇 |
1981年 | 4279篇 |
1979年 | 9534篇 |
1978年 | 6930篇 |
1977年 | 5833篇 |
1976年 | 5650篇 |
1975年 | 6456篇 |
1974年 | 7699篇 |
1973年 | 7198篇 |
1972年 | 7015篇 |
1971年 | 6739篇 |
1970年 | 6234篇 |
1969年 | 5973篇 |
1968年 | 5608篇 |
1967年 | 5092篇 |
1966年 | 4511篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Lykov A. P. Uvarov I. P. Gevorgiz R. G. Zheleznova S. N. 《Bulletin of experimental biology and medicine》2022,172(3):301-304
Bulletin of Experimental Biology and Medicine - We studied the effect of microalgae of various systematic groups added to the ration on the biochemical parameters of blood serum and liver and... 相似文献
2.
3.
Gordon K. B. Saburov V. O. Koryakin S. N. Gulidov I. A. Fatkhudinov T. Kh. Arutyunyan I. V. Kaprin A. D. Solov’ev A. N. 《Bulletin of experimental biology and medicine》2022,173(2):281-285
Bulletin of Experimental Biology and Medicine - Fast neutron therapy, which previously has demonstrated effective results, but along with a large number of complications, can again be considered a... 相似文献
4.
Zyuz’kov G. N. Zhdanov V. V. Miroshnichenko L. A. Polyakova T. Yu. Stavrova L. A. Simanina E. V. Minakova M. Yu. Agafonov V. I. Churin A. A. 《Bulletin of experimental biology and medicine》2022,173(5):615-619
Bulletin of Experimental Biology and Medicine - The psychopharmacological effects of a stimulator of functions of progenitor cells of the nervous tissue STAT3 inhibitor (STAT3 Inhibitor XIV, LLL12)... 相似文献
5.
6.
Improving hyperpolarized 129Xe ADC mapping in pediatric and adult lungs with uncertainty propagation
7.
Yevdulov O. V. Yevdulov D. V. Isabekova T. I. Aminov G. I. Aminova I. Yu. 《Biomedical engineering》2022,56(2):146-150
Biomedical Engineering - A mathematical model of a thermoelectric device for the treatment of whitlow by local hypothermia is discussed. The model is based on a solution of the heat conduction task... 相似文献
8.
9.
Kotsyuba A. E. Khramova I. A. Chertok V. M. Romanova T. E. 《Bulletin of experimental biology and medicine》2022,172(3):373-376
Bulletin of Experimental Biology and Medicine - Using the biomicroscopy method, we studied the reaction of arterial and venous vessels of the broad ligament of the uterus in outbred female rats to... 相似文献
10.
Koji Sasaki Tapan Kadia Kebede Begna Courtney D. DiNardo Gautam Borthakur Nicholas J. Short Nitin Jain Naval Daver Elias Jabbour Guillermo Garcia-Manero Guillermo Montalban Bravo Lucia Masarova Sherry Pierce Marina Konopleva Farhad Ravandi Ayalew Tefferi Hagop Kantarjian 《American journal of hematology》2022,97(1):68-78
The progress with intensive chemotherapy and supportive care measures has improved survival in patients with newly diagnosed acute myeloid leukemia (AML). Given the recent development of effective low intensity therapies, an optimal decision on the therapy intensity may improve survival through the avoidance of early mortality. We reviewed the outcome of 3728 patients with newly diagnosed AML who received intensive chemotherapy between August 1980 and May 2020. Intensive chemotherapy was defined as a cumulative cytarabine dose ≥ 700 mg/m2 during induction therapy. We divided the whole cohort into a training and validation group at a 3:1 ratio. The population was divided into a training (2790 patients) and a validation cohort (938 patients). The median age was 55 years (range, 15-99). Among them, 442 patients (12%) had core-binding factor AML. Binary logistic regression identified older age, worse performance status, hyperbilirubinemia, elevated creatinine, hyperuricemia, cytogenetic abnormalities other than CBF and -Y, and pneumonia as adverse prognostic factors for an early 4-week mortality. This risk classification for early mortality was verified in the validation cohort of patients. In the validation cohort of more recently treated patients from 2000 to 2017, the 4-week mortality rates with intensive chemotherapy were 2%, 14%, and 50% in the low-, high-, and very high-risk group, respectively. The mortality rates with low intensity therapies were 3%, 9%, and 20%, respectively. The risk classification guides treatment intensity by the assessment of age, frailty, organ dysfunction, cytogenetic abnormality, and infection to avoid early mortality. 相似文献